Article Information
History
- March 2, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Sven Strebel, MSc Pharm.1,2,3,
- Luzius Mader, PhD1,
- Philippa Jörger, MSc HST1,3,
- Nicolas Waespe, MD, PhD1,2,4,
- Seraina Uhlmann, BSc Pharm.1,
- Nicolas von der Weid, MD5,
- Marc Ansari, MD2,6 and
- Claudia E. Kuehni, MD, MSc1,4,✉
- 1Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
- 2CANSEARCH research platform in pediatric oncology and hematology, Department of Pediatrics, Gynecology and Obstetrics, University of Geneva, Geneva, Switzerland
- 3Graduate School for Health Sciences, University of Bern, Bern, Switzerland
- 4Division of Pediatric Hematology/Oncology, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
- 5Department of Pediatric Oncology and Hematology, University Children’s Hospital Basel (UKBB), University of Basel, Basel, Switzerland
- 6Department of Women, Child and Adolescent, Division of Pediatric Oncology and Hematology, Geneva University Hospital, University of Geneva, Geneva, Switzerland
- ↵✉Corresponding author Correspondence to: Claudia E. Kuehni, Prof. MD; Institute of Social and Preventive Medicine, University of Bern, Mittelstrasse 43, 3012 Bern, Switzerland; E-mail: claudia.kuehni{at}ispm.unibe.ch; Telephone: +41 31 684 35 07
Posted March 02, 2023.
Hearing loss after exposure to vincristine and platinum-based chemotherapy among childhood cancer survivors
